Stock listing

KRX:326030 SK Biopharmaceuticals Co., Ltd. (에스케이바이오팜) 주가

Follow SK Biopharmaceuticals Co., Ltd. into a list and get an email when it puts out news.

Share price · KRX:326030

₩79,300 KRW 0 (0.0%)

Delayed at least 15 minutes · 3:30 PM GMT+9, Nov 3, 2026

Past year -33.2% · daily closes, Nov 3, 2025 – Nov 3, 2026, adjusted for splits
Market cap
₩6.21T KRWDelayed at least 15 minutes · 3:30 PM GMT+9, Nov 3, 2026 · price × 78.31M shares outstanding
52-week range
₩67,800 – ₩144,100 KRWLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
Traded on an average day
₩10.59B KRWMedian day 116,059 shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
SK Biopharmaceuticals Co., Ltd. logo

Daily closes

Last 3 months, Aug 3, 2026 – Nov 3, 2026 · KRX:326030 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩79,300+1,800+2.3%₩78,000₩81,600₩77,500232,442
₩77,500-200-0.3%₩77,000₩78,500₩76,60069,267
₩77,700-100-0.1%₩78,000₩79,000₩76,000146,797
₩77,800+2,600+3.5%₩75,300₩78,300₩74,500203,355
₩75,200+300+0.4%₩75,100₩77,700₩74,900114,564
₩74,900-900-1.2%₩75,900₩77,200₩74,70095,674
₩75,800-1,100-1.4%₩76,000₩77,900₩75,250133,294
₩76,900+2,000+2.7%₩74,500₩77,800₩73,600213,698
₩74,900-100-0.1%₩74,000₩76,900₩73,000167,930
₩75,000+500+0.7%₩75,600₩76,800₩74,30082,643
₩74,500-1,700-2.2%₩75,200₩77,000₩73,50074,404
₩76,200+2,900+4.0%₩73,100₩76,400₩72,40087,150
₩73,300+3,900+5.6%₩69,300₩74,800₩69,100139,956
₩69,400-900-1.3%₩69,600₩69,900₩67,800136,126
₩70,300-400-0.6%₩70,800₩72,300₩69,50073,461
₩70,700-300-0.4%₩70,000₩70,900₩68,200109,303
₩71,000-1,700-2.3%₩72,500₩73,300₩70,60084,378
₩72,700-3,300-4.3%₩75,500₩75,600₩72,700155,627
₩76,000-600-0.8%₩77,700₩77,800₩75,80068,396
₩76,600+800+1.1%₩77,500₩78,000₩75,500102,498
₩75,800-900-1.2%₩76,700₩76,800₩75,10064,206
₩76,700+2,300+3.1%₩74,400₩76,700₩74,200109,873
₩74,400-500-0.7%₩75,400₩75,600₩74,40076,829
₩74,900-1,300-1.7%₩76,200₩76,200₩73,80099,352
₩76,200+300+0.4%₩76,300₩77,000₩75,90083,791
₩75,900-1,000-1.3%₩77,000₩77,400₩75,30092,324
₩76,900-700-0.9%₩78,100₩78,400₩76,70095,942
₩77,600-100-0.1%₩78,300₩78,700₩77,30095,089
₩77,700-1,500-1.9%₩80,000₩80,000₩77,600182,964
₩79,200+1,000+1.3%₩78,700₩80,400₩78,100119,118
₩78,200+100+0.1%₩78,100₩78,500₩77,30081,532
₩78,100-1,000-1.3%₩78,200₩79,200₩77,70088,128
₩79,100-300-0.4%₩78,500₩80,500₩77,100117,553
₩79,400-4,000-4.8%₩79,400₩80,200₩77,200165,820
₩83,400-400-0.5%₩82,800₩83,900₩81,600215,020
₩83,800+600+0.7%₩82,700₩84,200₩82,20089,675
₩83,200-1,800-2.1%₩85,800₩86,200₩83,200112,608
₩85,000-1,600-1.8%₩86,200₩86,400₩84,200120,957
₩86,600+200+0.2%₩87,000₩87,300₩85,70066,264
₩86,400+100+0.1%₩86,600₩88,700₩85,000124,409
₩86,300-2,700-3.0%₩87,800₩88,600₩85,90088,027
₩89,000+1,700+1.9%₩86,900₩90,400₩86,900156,029
₩87,300-700-0.8%₩86,900₩87,600₩83,800119,227
₩88,00000.0%₩88,500₩90,000₩86,600124,302
₩88,000-3,600-3.9%₩90,900₩91,500₩87,400172,803
₩91,600+7,200+8.5%₩85,300₩94,800₩84,800597,598
₩84,400-2,000-2.3%₩86,300₩86,400₩82,600127,621
₩86,400+2,700+3.2%₩84,500₩86,400₩83,900101,599
₩83,700-2,800-3.2%₩84,900₩85,200₩81,900120,200
₩86,500+1,200+1.4%₩87,600₩88,600₩85,800152,325
₩85,300+100+0.1%₩83,600₩85,600₩82,100101,900
₩85,200-2,100-2.4%₩86,400₩87,100₩84,100102,589
₩87,300-300-0.3%₩87,700₩88,700₩86,10099,781
₩87,600-600-0.7%₩88,800₩89,200₩87,000152,594
₩88,200-2,300-2.5%₩90,600₩90,600₩88,000114,069
₩90,500+1,800+2.0%₩88,600₩92,700₩88,500181,751
₩88,700+3,300+3.9%₩85,100₩89,000₩83,800138,032
₩85,400+1,900+2.3%₩82,700₩85,400₩82,000136,799
₩83,500+1,500+1.8%₩82,400₩84,600₩80,300166,425
₩82,000+2,200+2.8%₩81,600₩86,300₩80,700196,091
₩79,800+1,400+1.8%₩78,000₩80,400₩77,700119,364
₩78,400-600-0.8%₩78,500₩79,700₩76,200111,869
Ticker
KRX:326030
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
KRX
Currency
KRW

What changed lately

Latest news

SK Life Science, Inc. to Present New Data and Epilepsy Insights at the 2026 American Academy of Neurology Annual Meeting

Apr 6, 2026

Closed ₩95,100 (-0.7%) on Apr 7, 2026

SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation

Nov 26, 2025

Closed ₩139,100 (-1.1%) on Nov 27, 2025

SK Life Science, Inc. to Present 10 Posters with New Cenobamate Data, Including a Late-Breaker, at the 2025 American Epilepsy Society (AES) Annual Meeting

Nov 21, 2025

Closed ₩128,300 (+1.4%) on Nov 24, 2025

New SK Life Science, Inc. Survey Reveals Communication Gaps Between Patients and Providers That Can Impact Epilepsy Care Outcomes

Oct 28, 2025

SK Life Science, Inc. to Host "Illuminating the Path to Added Seizure Reduction" Symposium at the 2025 American Epilepsy Society Annual Meeting

Oct 24, 2025

SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform

Oct 20, 2025

All SK Biopharmaceuticals Co., Ltd. news

Decks

SK Biopharmaceuticals Co., Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
3 in the last 12 months · 6 in all · newest Apr 6, 2026 · oldest 2025
Decks
4 decks · latest Aug 5, 2026

Log in to ask 6ix AI your own questions about SK Biopharmaceuticals Co., Ltd.